End-stage Renal Disease
Higher magnesium levels in hemodialysis patients with high phosphorus levels were associated with decreased cardiovascular mortality.
Even though rate of disease is on the rise, fewer patients are suffering organ failure or dying
Decreased risk of ESRD was observed in individuals without the metabolic syndrome.
The risk of end-stage renal disease in patients with systemic lupus erythematosus may even be declining, but outcomes differ by race.
For patients at high risk of cardiovascular disease, resting heart rate predicts renal outcomes singly and in combination.
Osteoporosis is significantly associated with an elevated likelihood of coronary artery disease, congestive heart failure, and stroke.
This intervention in patients with chronic kidney disease reduced by 28% their risk of death after progressing to end-stage renal disease.
In the fight against kidney disease, greater gains may be realized by focusing on personal economy.
The risk is 2.6 times greater among postmenopausal women with waists larger than 88 cm
Every 1 mg/dL increase in serum phosphorus was independently associated with a 36% increased relative risk of kidney failure.
Recently, increasing attention focused on mineralocorticoid receptor antagonists (MRAs) in treating chronic kidney disease (CKD).
Strenuous aerobic activities found to decrease the risk of ESRD by 42% compared with no physical activity.
Study shows that 59% of men with end-stage renal disease were on hemodialysis versus 41% of women.
But targeting an HbA1c level below 6.5% is associated with a decreased risk of end-stage renal disease.
Large study looked at matched pairs of lupus patients with renal disease starting dialysis with hemodialysis or peritoneal dialysis.
In adjusted analyses, female transplant recipients had a significantly increased risk of urologic cancer and men did not.
One hospitalization for associated with a 4.9-fold increased risk of end-stage renal disease.
Study reveals circadian variation in phosphate, parathyroid hormone, and 25-hydroxyvitamin D levels in patients with end-stage renal disease.
Improved renal function may contribute to the decline in a glycoprotein that inhibits bone formation.
Investigators used a novel algorithm to characterize this rare and often life-threatening disorder seen mostly in ESRD patients.
Patients are more likely to receive a kidney transplant and less likely to die than patients with end-stage renal disease from other causes.
Proteinuria, hypertension, and obesity in adolescence independently predict development of end-stage renal disease.
The finding is from a study of more than 5 million Norwegians.
Researchers find a greater than 50% reduction in end-stage renal disease risk compared with radical nephrectomy.
Would any heterogeneity in the choice of additional services be unethical or implausible?
It is associated with better long-term survival and reduced risk of revascularization and myocardial infarction compared with PCI.
Distinguishing primary from secondary focal segmental glomerulosclerosis is crucial because the treatment approaches and therapeutic goals differ.
They also are at elevated risk of cardiovascular and all-cause mortality, study finds.
Hepatitis C virus infection increases CKD patients' likelihood of progressing to end-stage renal disease by 32%.
Heart failure, myocardial infarction, or stroke also increase the risk of death prior to ESRD.
- Post-RARP Potency, Continence Return Faster with Amniotic Nerve Wrap
- MRI-Guided Prostate Biopsy Spots More Aggressive Tumors
- Dialysis Patients with Hyperphosphatemia May Benefit from Magnesium
- Cooking Methods May Help Dialysis Patients Control Phosphorus
- Antimicrobial Prophylaxis Overused for Urological Surgeries
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)